A 8-K Current Reports
AGILENT TECHNOLOGIES, INC. - 315 current reports
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Aug 26, 2026)
Agilent Technologies, Inc. has filed an 8-K report on August 26, 2026, to announce its financial results for the third fiscal quarter ended July 31, 2026. The filing primarily consists of a press release (Exhibit 99.1) detailing these results. Investors should note that Agilent provides both GAAP and non-GAAP financial information, emphasizing that the non-GAAP measures are intended to offer supplemental insights into operational performance and are used by management for internal comparisons and decision-making. These non-GAAP figures exclude items like restructuring and amortization, which can materially impact GAAP earnings, and are presented to give investors a view of the company's performance "through the eyes of management." While the specific financial figures are detailed in the attached press release, the core of this 8-K is the disclosure of the company's quarterly performance. Investors are encouraged to review Exhibit 99.1 for the detailed financial metrics, segment performance, and specific non-GAAP reconciliations, as this information is crucial for understanding the company's current operational health and future prospects. The company stresses that its non-GAAP information may differ from that of other companies and is not a substitute for GAAP reporting.
AGILENT TECHNOLOGIES, INC. 8-K Report, Material Agreement (Jun 25, 2026)
Agilent Technologies, Inc. announced on June 25, 2026, the successful closing of a $600 million offering of 4.900% Senior Notes due 2032. These notes were sold in a private placement to qualified institutional buyers and offshore investors. The offering was conducted under Rule 144A and Regulation S, with Citigroup Global Markets Inc., Mizuho Securities USA LLC, and SG Americas Securities, LLC acting as the initial purchasers. The issuance of these notes, governed by an indenture originally dated March 12, 2021, and supplemented by a Fourth Supplemental Indenture dated June 25, 2026, represents a significant debt financing for the company. The notes bear a fixed annual interest rate of 4.900%, payable semi-annually, and mature on January 15, 2032. While these notes are senior unsecured obligations, they are not guaranteed by any subsidiaries. The company has also entered into a registration rights agreement to facilitate an exchange offer for these notes, with provisions for additional interest if certain registration deadlines are not met.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (May 27, 2026)
Agilent Technologies, Inc. (A) filed an 8-K on May 27, 2026, primarily to disclose financial results for its second fiscal quarter ended April 30, 2026. The filing includes a press release (Exhibit 99.1) detailing these results, alongside an explanation of the company's use of non-GAAP financial measures. Investors should note that the company emphasizes providing these non-GAAP figures to offer a clearer view of operational performance and future prospects, supplementing its GAAP reporting. These non-GAAP measures exclude items such as restructuring and amortization, which management monitors but does not use for ongoing operating performance evaluation. Additionally, the 8-K announces a key leadership change within the finance department. Tim Downs has been appointed as the new Vice President, Chief Accounting Officer, and principal accounting officer, effective after the filing of the Q2 10-Q. This appointment follows the previously announced retirement of Rodney Gonsalves, who will remain with the company in a transitional role until January 2027. Mr. Downs brings extensive experience from Baker Hughes and prior roles at General Electric and Deloitte. His compensation package includes a base salary, bonus eligibility, a sign-on cash bonus, and a significant restricted stock unit grant.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 4, 2026)
Agilent Technologies, Inc. filed an 8-K report on May 4, 2026, primarily to disclose a significant executive appointment. The company announced the appointment of Michael Buckner as its new Chief Legal Officer (CLO). This appointment marks a key change in the company's senior leadership, filling a critical legal and compliance role. Investors should note that this information is being furnished under Regulation FD and is not considered "filed" for purposes of the Securities Exchange Act of 1934, meaning it does not carry the same legal liabilities as a formally filed document but still provides important operational updates.
AGILENT TECHNOLOGIES, INC. 8-K/A Report, Executive Changes (Apr 6, 2026)
Agilent Technologies, Inc. filed an 8-K on April 6, 2026, primarily to disclose a Transition and General Release Agreement with Bret DiMarco, dated March 31, 2026. While this filing doesn't contain typical financial results or operational updates, the agreement's existence suggests a departure or separation involving Mr. DiMarco, who may be a significant executive or board member. Investors should note that details of this agreement, such as severance packages or ongoing obligations, are not provided in this exhibit list. The filing also includes the standard Cover Page Interactive Data File.
AGILENT TECHNOLOGIES, INC. 8-K Report, Change in Control (Apr 3, 2026)
Agilent Technologies, Inc. (A) filed an 8-K on April 3, 2026, primarily to disclose a Transition and General Release Agreement with Bret DiMarco, dated March 31, 2026. While the filing does not contain significant financial updates or operational changes, the agreement with Mr. DiMarco, a former executive, is a key event. The details of this agreement, likely outlining separation terms, compensation, and release of claims, are crucial for understanding potential future financial impacts or legal resolutions related to his departure. Investors should review the full agreement for specifics on severance, equity awards, and any non-compete or non-disparagement clauses that could affect the company.
AGILENT TECHNOLOGIES, INC. 8-K Report, Bylaw Amendment (Mar 20, 2026)
Agilent Technologies, Inc. has filed an 8-K report detailing the outcomes of its Annual Meeting of Stockholders held on March 18, 2026. The most significant development for investors is the approval of amendments to the Company's Certificate of Incorporation and Bylaws, which will implement a phased declassification of the Board of Directors over a three-year period. This change, effective upon the filing of the Certificate of Incorporation with the Delaware Secretary of State on March 19, 2026, moves away from a classified board structure towards annual election of all directors. In addition to the governance changes, the meeting saw the election of four directors to three-year terms, with strong affirmative votes. Stockholders also overwhelmingly approved the company's executive compensation on a non-binding advisory basis and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year 2026. The high turnout and overwhelming approval of these proposals indicate broad shareholder support for the company's direction and governance.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Mar 6, 2026)
Agilent Technologies, Inc. filed an 8-K on March 6, 2026, primarily to disclose its exhibits. The core of this filing is the inclusion of the Cover Page Interactive Data File, which is embedded within the Inline XBRL document. This exhibit format is standard for SEC filings and provides structured data for financial reporting and analysis tools. Investors should note that this particular 8-K does not contain any new material financial results, business updates, or material agreements, but rather focuses on the technical presentation of the company's reporting data. While this filing is routine in nature, it signifies Agilent's commitment to transparent and accessible financial disclosure through modern reporting standards. Investors can leverage the interactive data file to more easily extract and analyze the company's financial information. For deeper insights into Agilent's financial performance and strategic direction, investors should refer to other filings that contain more substantive business and financial disclosures, such as quarterly earnings reports (10-Q) or annual reports (10-K).
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Feb 25, 2026)
Agilent Technologies, Inc. (A) filed an 8-K on February 25, 2026, to announce its financial results for the first fiscal quarter ended January 31, 2026. The report primarily consists of a press release (Exhibit 99.1) detailing these results. Investors should note that the company is providing non-GAAP financial information alongside GAAP results to offer a clearer view of its ongoing operational performance and future prospects, as assessed by management. The company emphasizes that its non-GAAP measures are intended to supplement, not replace, GAAP reporting, offering insights into core financial performance and facilitating comparisons with historical data and competitors. These non-GAAP figures exclude certain items like restructuring and amortization expenses, which, while monitored by management, are not used to evaluate the company's core operating performance. Investors are encouraged to review the full press release for detailed financial figures and a comprehensive explanation of the non-GAAP metrics used.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Nov 24, 2025)
Agilent Technologies, Inc. has filed an 8-K to report its financial results for the fourth fiscal quarter ended October 31, 2025. The filing primarily consists of a press release (Exhibit 99.1) detailing these results and provides significant emphasis on the company's use of non-GAAP financial measures. Agilent believes these non-GAAP metrics offer a more meaningful view of operational performance and allow investors to understand results from management's perspective, facilitating comparisons with historical data and competitors. This approach aims to provide greater transparency into the financial and operational decision-making processes of the company.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Oct 27, 2025)
Agilent Technologies, Inc. (A) announced a significant leadership change with the appointment of Adam S. Elinoff as its new Senior Vice President and Chief Financial Officer (CFO), effective November 17, 2025. Mr. Elinoff brings extensive financial experience from his tenure at Amgen Inc., where he held various senior finance, strategy, and investor relations roles. This appointment marks the transition from Rodney Gonsalves, who has been serving as Interim CFO. The company has also outlined a comprehensive compensation package for Mr. Elinoff, including a base salary of $700,000, eligibility for an annual bonus, and substantial equity awards in the form of restricted stock units (RSUs) and performance-based RSUs. These awards are designed to incentivize long-term performance and retention, with vesting schedules and performance criteria tied to the company's financial success. The appointment and compensation details are intended to signal a strategic focus on financial leadership and stability.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Aug 27, 2025)
Agilent Technologies, Inc. has filed an 8-K report on August 27, 2025, to announce its financial results for the third fiscal quarter ended July 31, 2025. The report primarily contains a press release detailing these results, which are presented on both a GAAP and non-GAAP basis. The company emphasizes the use of non-GAAP measures to provide investors with a clearer view of operational performance and future prospects, excluding items such as restructuring and amortization that management does not consider reflective of ongoing operational performance. Investors should note that the provided non-GAAP figures are supplementary and may differ from those presented by other companies. The press release, attached as Exhibit 99.1, offers a more detailed explanation of these non-GAAP adjustments and should be reviewed in conjunction with the company's official GAAP financial statements. The inclusion of this non-GAAP information is a consistent practice by Agilent to enhance transparency and comparability for its stakeholders.
AGILENT TECHNOLOGIES, INC. 8-K/A Report, Executive Changes (Aug 8, 2025)
Agilent Technologies, Inc. (A) filed an 8-K on August 8, 2025, primarily to announce changes to the compensation package for Mr. Gonsalves following his appointment as interim Chief Financial Officer and interim Principal Financial Officer. This change is effective July 31, 2025, and includes a bi-weekly salary stipend of $8,654 for the duration of his interim role. Additionally, Mr. Gonsalves will receive a grant of restricted stock units (RSUs) with a target value of $1,000,000, subject to the terms of Agilent's 2018 Stock Plan.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Jul 15, 2025)
Agilent Technologies, Inc. (A) announced a significant leadership change in its finance department via an 8-K filing on July 15, 2025. Effective July 31, 2025, Robert W. McMahon will be stepping down as Senior Vice President and Chief Financial Officer (CFO). The company explicitly stated that Mr. McMahon's departure is amicable and not due to any disagreements concerning accounting practices, financial statements, internal controls, or operational matters, which should provide some reassurance to investors regarding financial integrity. In parallel, Agilent has appointed Rodney Gonsalves as the interim CFO and interim Principal Financial Officer, also effective July 31, 2025. Mr. Gonsalves is a known quantity within the company, currently serving as Vice President, Corporate Controller, and Principal Accounting Officer. This interim appointment aims to ensure a smooth transition and continuity in financial leadership. Investors will be monitoring the company's communication for further updates on a permanent CFO selection.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (May 28, 2025)
Agilent Technologies, Inc. has filed an 8-K report detailing its financial results for the second fiscal quarter ended April 30, 2025. The report primarily consists of a press release announcing these results, which is furnished as an exhibit. The company emphasizes its use of non-GAAP financial measures to provide investors with a clearer view of its operational performance and future prospects, supplementing its standard GAAP reporting. These non-GAAP measures are used internally by management to assess performance and make strategic decisions, offering insights into the company's core financial health by excluding items like restructuring and amortization that can impact GAAP earnings per share.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 21, 2025)
Agilent Technologies, Inc. announced significant governance changes on May 21, 2025, through an 8-K filing. The Board of Directors has been expanded from 10 to 12 members with the appointment of two new independent directors, Pascal Soriot and Judy Gawlik Brown. Mr. Soriot brings extensive leadership experience from the pharmaceutical industry, most notably as CEO of AstraZeneca, while Ms. Brown offers deep financial and operational expertise from roles at Amgen, Perrigo, and as founder of Downtown Advisory, along with her current independent director experience at Belden Inc. In addition to the board expansion, Agilent's bylaws were amended to lower the supermajority voting threshold for certain corporate actions from 80% to a simple majority. This change aims to streamline decision-making processes. Both new directors have been deemed independent and will receive standard non-employee director compensation. These moves suggest a strategic effort to enhance board oversight and potentially improve corporate agility.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 2, 2025)
Agilent Technologies, Inc. announced the resignation of Henrick Ancher-Jensen, Senior Vice President and President of Order Fulfillment and Supply Chain, effective June 1, 2025. Mr. Ancher-Jensen is departing to pursue another opportunity. This departure, while effective in early June, is being disclosed now to provide timely information to investors. The company has also filed its 8-K, which primarily serves to report this executive change and includes the standard Cover Page Interactive Data File as an exhibit. Investors should monitor any subsequent filings for information regarding the transition plan for Mr. Ancher-Jensen's responsibilities and the appointment of a successor, as this is a key role within the company's operational structure.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Apr 2, 2025)
Agilent Technologies, Inc. (AGIL) has filed an 8-K report primarily disclosing the resignation of a key board member, Heidi Kunz, effective May 21, 2025. Ms. Kunz, who served on both the Compensation Committee and the Nominating/Corporate Governance Committee, is stepping down from her director role. Importantly, the filing explicitly states that her resignation is not a result of any disagreements related to the company's operations, policies, or practices. The company expressed gratitude for her contributions.
AGILENT TECHNOLOGIES, INC. 8-K Report, Shareholder Vote Results (Mar 17, 2025)
Agilent Technologies, Inc. filed an 8-K on March 17, 2025, detailing the outcomes of its Annual Meeting of Stockholders held on March 13, 2025. The meeting saw strong participation, with approximately 88.18% of outstanding shares represented. Key outcomes include the election of two new directors, Otis W. Brawley, M.D., and Mikael Dolsten, M.D., Ph.D., for three-year terms, with broad shareholder support. All other incumbent directors will continue in their roles. Furthermore, shareholders provided advisory approval for the compensation of named executive officers and ratified the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2025. The company also saw significant approval for amendments to its Certificate of Incorporation to remove supermajority voting requirements, indicating a move towards simpler governance. A shareholder proposal to elect directors annually also received substantial support, suggesting a preference for annual director elections.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Mar 3, 2025)
Agilent Technologies, Inc. has announced a significant restructuring of its business segments, effective from November 2024, which is being formally disclosed in this 8-K filing. The company has reorganized into three new reportable segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. This change is driven by a strategy to enhance market focus and customer centricity. Investors should note that this filing primarily serves to provide recast financial information for the company's Annual Report on Form 10-K for the year ended October 31, 2024, to reflect these new segment structures. It does not introduce new financial results or update the Management's Discussion and Analysis for events after the 10-K filing date. For the most current financial performance and forward-looking information, investors are directed to Agilent's subsequent Quarterly Report on Form 10-Q for the period ended January 31, 2025, and other SEC filings.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Feb 26, 2025)
Agilent Technologies, Inc. has filed an 8-K report on February 26, 2025, to announce its financial results for the first fiscal quarter ended January 31, 2025. The report primarily consists of a press release (Exhibit 99.1) detailing these results. The company emphasizes its use of non-GAAP financial measures, stating they provide a more meaningful view of operational performance and are used by management for decision-making and comparisons. While the full financial details are within the attached press release, the key takeaway for investors is that Agilent is providing supplemental non-GAAP information to offer greater transparency into its core business performance. This approach excludes certain GAAP-recognized items like restructuring and amortization, which management monitors but does not consider indicative of ongoing operating performance. Investors should refer to Exhibit 99.1 for the specific figures and a detailed explanation of these non-GAAP metrics and their reconciliation to GAAP.
AGILENT TECHNOLOGIES, INC. 8-K Report, Regulation FD Disclosure (Dec 13, 2024)
Agilent Technologies, Inc. has announced a significant reorganization of its operational structure, effective for financial reporting beginning with the quarter ending January 31, 2025. The company is shifting to a market-focused, customer-centric strategy, which will be reflected in three newly defined reportable business segments: Life Sciences and Diagnostics Markets, Applied Markets, and Agilent CrossLab. This change aims to better align the company's operations with its strategic goals and provide clearer insights into performance across these key areas. This 8-K filing provides investors with selected unaudited historical financial information recast under these new segments. While this information is being furnished and not formally filed for Section 18 liability, it offers a preview of how Agilent's past performance will be presented moving forward. Investors should note that prior periods will be restated accordingly, enabling a more consistent comparison once the new structure is fully implemented.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Nov 25, 2024)
Agilent Technologies, Inc. has filed an 8-K report on November 25, 2024, to announce its financial results for the fourth fiscal quarter ended October 31, 2024. The report primarily includes a press release (Exhibit 99.1) detailing these results. Investors should note that Agilent provides both GAAP and non-GAAP financial information, with the latter presented to offer a clearer view of operational performance and future prospects as seen by management. While the non-GAAP measures aim to enhance understanding of core financial performance by excluding items like restructuring and amortization, they are not a substitute for GAAP and may differ from non-GAAP presentations by other companies. The company emphasizes that these non-GAAP metrics are used internally for performance measurement and comparison. Investors are encouraged to review the full press release in Exhibit 99.1 for a comprehensive understanding of the financial outcomes and the detailed reconciliation between GAAP and non-GAAP figures.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Nov 25, 2024)
Agilent Technologies, Inc. has announced a significant reorganization of its operational structure, effective with its first quarter fiscal year 2025 results. The company will now report under three distinct business groups: Life Sciences and Diagnostics Markets Group, Applied Markets Group, and Agilent CrossLab Group. This strategic move aims to align the company's reporting structure with its operational focus, potentially leading to greater clarity for investors regarding segment performance and strategic initiatives within each area. This reorganization is a forward-looking development that investors should monitor closely. The new structure is expected to provide a more granular view of Agilent's performance across its key markets, enabling better assessment of growth drivers and strategic execution. While the filing does not provide financial details of the reorganization's impact, it signals a proactive approach by management to adapt its structure to evolving market dynamics and enhance operational efficiency and transparency.
AGILENT TECHNOLOGIES, INC. 8-K Report, Material Agreement (Sep 9, 2024)
Agilent Technologies, Inc. has successfully closed a public offering of $1.2 billion in aggregate principal amount of senior notes. This issuance comprises $600 million of 4.200% Senior Notes due 2027 and $600 million of 4.750% Senior Notes due 2034. The proceeds from this offering will be used to fund the company's operations and strategic initiatives. The new notes are unsecured and rank equally with Agilent's existing senior unsecured indebtedness. The terms include provisions for redemption by the company under specific conditions, including a 'Par Call Date' and a 'Change of Control Repurchase Event.' Notably, the 2027 Notes are subject to a special mandatory redemption at a higher principal amount (101%) if the 'BioVectra Acquisition' is not completed by a specified date or if Agilent decides not to proceed with it. This indicates the acquisition is a significant factor tied to the financing.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Sep 5, 2024)
Agilent Technologies, Inc. has announced the issuance and sale of $1.2 billion in aggregate principal amount of senior notes through an underwritten public offering. The offering consists of $600 million of 4.200% Senior Notes due 2027 and $600 million of 4.750% Senior Notes due 2034. These notes are unsecured and will rank equally with other senior unsecured indebtedness of the company. The offering is expected to close on September 9, 2024, subject to customary closing conditions.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Sep 3, 2024)
Agilent Technologies, Inc. filed a Current Report on Form 8-K to incorporate by reference information from its previous filings, specifically to reflect a change in its operating segment reporting structure. The company has recasted its historical financial segment information to align with a reorganization announced in the first quarter of fiscal year 2024. This reorganization moved the cell analysis business from the 'Life Sciences and Applied Markets' segment to the 'Diagnostics and Genomics' segment. This 8-K filing serves to update the presentation of segment data within previously filed documents, primarily the Annual Report on Form 10-K for the year ended October 31, 2023. Investors should note that this report does not contain new financial information or updates on subsequent events beyond the segment recasting. For the most current financial performance and events, investors should refer to Agilent's most recent Form 10-Q filing for the quarter ended July 31, 2024.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Aug 21, 2024)
Agilent Technologies, Inc. has filed an 8-K report on August 21, 2024, to announce its financial results for the third fiscal quarter ended July 31, 2024. The report primarily consists of a press release (Exhibit 99.1) detailing these results. Agilent continues to emphasize its use of non-GAAP financial measures to provide a more insightful view of its operational performance and future prospects, explaining that these metrics are used internally by management and allow for better comparison to historical and competitor results, while also acknowledging that they exclude items like restructuring and amortization that impact GAAP figures.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (May 29, 2024)
Agilent Technologies, Inc. announced its financial results for the second fiscal quarter ended April 30, 2024, alongside a significant capital allocation update. The company is implementing a new stock repurchase program authorizing up to $2 billion of common stock, demonstrating confidence in its financial position and a commitment to returning value to shareholders. This program is set to begin on August 1, 2024, or upon the full utilization of the existing repurchase program, indicating a strategic approach to managing its capital. The company also reiterated its practice of providing non-GAAP financial measures, explaining their utility in offering a clearer view of operational performance by excluding items like restructuring and amortization. Investors are encouraged to review the accompanying press release (Exhibit 99.1) for a detailed breakdown of these results and a comprehensive understanding of the non-GAAP adjustments, which management uses for performance evaluation and strategic decision-making.
AGILENT TECHNOLOGIES, INC. 8-K/A Report, Executive Changes (May 24, 2024)
Agilent Technologies, Inc. (A) filed an 8-K on May 24, 2024, primarily detailing the compensation package for its newly appointed CEO, Mr. McDonnell. Effective June 1, 2024, Mr. McDonnell will receive an annual base salary of $1,075,000 and a target performance bonus of 125%. This compensation structure reflects the company's commitment to incentivizing its top executive. Further details include significant equity awards totaling $3,300,000, effective June 3, 2024, consisting of performance-based RSUs, time-based RSUs, and stock options. This award is part of Mr. McDonnell's total FY2024 equity award of $7,500,000, with a portion previously granted. Investors should note this filing focuses solely on executive compensation adjustments following the CEO transition and does not include operational or financial performance updates.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 24, 2024)
Agilent Technologies, Inc. (A) filed an 8-K on May 24, 2024, primarily announcing the departure of a board member, Hans E. Bishop. Mr. Bishop stepped down from the Board of Directors effective May 23, 2024, after serving since 2017. His departure is stated to be unrelated to any disagreements concerning the Company's operations, policies, or practices, which is a positive signal for investors regarding internal stability. This change resulted in a reduction of the Board size from eleven to ten directors. The company also issued a press release on May 23, 2024, to formally announce this board change. While this is a change in board composition, it does not appear to signal any immediate operational or strategic shifts for Agilent.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (May 1, 2024)
Agilent Technologies, Inc. (A) filed an 8-K on May 1, 2024, primarily to announce a significant leadership transition. Effective May 1, 2024, Michael McMullen retired as President and CEO and from the Board of Directors, concluding his tenure. Mr. McMullen will remain with the company in a senior advisor role until October 31, 2024, providing a transition period. In conjunction with Mr. McMullen's retirement, the Board of Directors has appointed Padraig McDonnell as the new President and CEO, effective May 1, 2024. Mr. McDonnell has also been appointed to the Board. Investors should note that the Board is scheduled to review and potentially adjust Mr. McDonnell's compensation package on May 21, 2024. A press release detailing Mr. McDonnell's appointment was issued on the same day.
AGILENT TECHNOLOGIES, INC. 8-K Report, Shareholder Vote Results (Mar 15, 2024)
Agilent Technologies, Inc. (A) filed an 8-K on March 15, 2024, detailing the results of its Annual Meeting of Stockholders held on March 14, 2024. The meeting saw strong participation, with approximately 91% of outstanding shares represented. All proposals presented to shareholders received overwhelming approval, indicating robust support for the company's current leadership and strategic direction. Key outcomes include the election of four directors to three-year terms, the approval of executive compensation through a non-binding advisory vote, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for fiscal year 2024. Additionally, a shareholder proposal regarding a simple majority vote was also approved. The overwhelming support across all proposals suggests shareholder confidence in Agilent's governance and financial oversight.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Feb 27, 2024)
Agilent Technologies, Inc. filed an 8-K on February 27, 2024, to announce its financial results for the first fiscal quarter ended January 31, 2024. The report primarily consists of a press release (Exhibit 99.1) detailing these results. The company emphasizes its use of non-GAAP financial measures to offer investors a clearer view of operational performance and future prospects, as seen through management's eyes, alongside the standard GAAP reporting. This disclosure serves to provide investors with supplemental information that management uses internally for performance evaluation and comparisons. While these non-GAAP measures exclude items like restructuring and amortization that impact GAAP earnings, they are presented to enhance transparency and allow for a better understanding of the company's core ongoing financial performance. Investors should note that the specific non-GAAP metrics used by Agilent may differ from those reported by other companies.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Feb 21, 2024)
Agilent Technologies, Inc. (A) announced on February 21, 2024, that its President and CEO, Michael McMullen, will retire from his roles on May 1, 2024. Mr. McMullen will transition to a senior advisor role until October 31, 2024. This leadership change marks the end of a significant tenure for Mr. McMullen. Concurrently, the Board has appointed Padraig McDonnell, currently a Senior Vice President, as Chief Operating Officer (COO) and CEO-elect. Mr. McDonnell is slated to assume the CEO position upon Mr. McMullen's retirement and will be nominated to the Board. His appointment is accompanied by a revised compensation package, including a base salary increase, enhanced performance-based compensation targets, and significant equity awards comprising stock options, RSUs, and performance-based RSUs, reflecting his new responsibilities and long-term commitment to Agilent.
AGILENT TECHNOLOGIES, INC. 8-K Report, Regulation FD Disclosure (Jan 5, 2024)
Agilent Technologies, Inc. (A) has filed an 8-K report on January 5, 2024, to disclose a change in its business segment reporting structure. Effective for the quarter ending January 31, 2024, the company is moving its Cell Analysis Division from the Life Sciences and Applied Markets Group (LSAG) to the Diagnostics and Genomics Group (DGG). This strategic reorganization aims to enhance growth opportunities within both affected divisions. This change will result in a restatement of prior period financial information to align with the new segment structure. Investors should note that the report includes selected segment information for historical periods (fiscal quarters and years from 2021 to 2023) reflecting this updated organization, which will be incorporated into future financial statements. The information provided is furnished and not deemed filed under Section 18 of the Securities Exchange Act.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Dec 20, 2023)
Agilent Technologies, Inc. has announced a significant change in its reporting structure, moving its Cell Analysis Division into its Diagnostics and Genomics Group, effective with its first quarter fiscal 2024 results. This strategic realignment is intended to better align operations and potentially enhance reporting clarity for investors. The company plans to provide three years of historical financial data adjusted for this new structure in January 2024, facilitating a more accurate comparison of past and future performance across these segments.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Nov 20, 2023)
Agilent Technologies, Inc. (A) filed an 8-K on November 20, 2023, to announce its financial results for the fourth fiscal quarter ended October 31, 2023. The report primarily consists of a press release (Exhibit 99.1) detailing these results. The company emphasizes its use of non-GAAP financial information to provide investors with a clearer view of its core operational performance and future prospects, as measured by management. This non-GAAP information supplements GAAP results by excluding certain items like restructuring and amortization, which are monitored but not used for ongoing performance assessment.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Nov 1, 2023)
Agilent Technologies, Inc. has announced a significant leadership change with the resignation of Sam Raha, Senior Vice President and President of the Diagnostics and Genomics Group (DGG). Mr. Raha will be departing the company on December 8, 2023, to pursue another opportunity. This departure marks the end of his tenure leading a critical segment of Agilent's business. Investors should monitor the company's succession plan and the transition process within the DGG segment, as leadership stability is crucial for operational continuity and strategic execution.
AGILENT TECHNOLOGIES, INC. 8-K Report, Executive Changes (Sep 5, 2023)
Agilent Technologies, Inc. has announced a significant leadership change with the resignation of Jacob Thaysen from his roles as Senior Vice President and President of the Life Sciences and Applied Markets Group (LSAG), effective September 5, 2023. This departure marks a key event for investors to monitor as the LSAG segment is a critical component of Agilent's overall business, contributing substantially to revenue and growth. Investors should look for updates on the interim or permanent replacement for this position and any potential strategic implications or operational adjustments within the LSAG segment following Mr. Thaysen's exit.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Aug 15, 2023)
Agilent Technologies, Inc. has released its financial results for the third fiscal quarter ended July 31, 2023. The company provided both GAAP and non-GAAP financial information, emphasizing that the non-GAAP figures are intended to offer supplemental insights into operational performance and management's view of the core business. These non-GAAP measures exclude certain items like restructuring and amortization to better reflect ongoing operating performance and facilitate comparisons to historical results and competitors. Investors should note that the detailed financial results, including specific revenue and earnings figures, are presented in the press release attached as Exhibit 99.1. The company utilizes non-GAAP metrics to provide a more transparent view of its financial health and strategic performance, as monitored by its management. While these figures are not prepared in accordance with U.S. GAAP, they are presented consistently with the company's historical reporting practices.
AGILENT TECHNOLOGIES, INC. 8-K Report, Material Agreement (Jun 13, 2023)
Agilent Technologies, Inc. (Agilent) has entered into a new $1.5 billion five-year unsecured credit facility, maturing on June 7, 2028. This facility replaces a previous credit agreement and provides Agilent with significant financial flexibility for general corporate purposes. The company has the option to increase the facility size by up to an additional $750 million, subject to lender commitments and customary conditions, and can also extend the maturity date by one year. The new credit facility offers competitive interest rates based on Agilent's senior debt credit ratings. At its current ratings, the applicable margin for alternate base rate loans is 0.000%, and for Term Rate or SONIA rate loans, it is 0.910%. Additionally, Agilent will pay a quarterly facility fee of 0.090% on the total commitments, amounting to approximately $1.35 million annually at current ratings. The agreement includes standard covenants and financial covenants, such as a maximum ratio of adjusted consolidated financial indebtedness to consolidated capitalization of 0.65 to 1.00.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (May 23, 2023)
Agilent Technologies, Inc. announced its financial results for the second fiscal quarter ended April 30, 2023, through a press release filed on May 23, 2023. The company provided both GAAP and non-GAAP financial information, emphasizing that the non-GAAP figures are intended to offer a clearer view of operational performance and core financial trends by excluding items like restructuring and amortization. Investors are encouraged to review the non-GAAP data, as management uses these metrics for internal performance assessments and comparisons with industry peers, believing it enhances understanding of the company's ongoing operational health and future prospects. While the specific financial figures are detailed in the attached press release (Exhibit 99.1), the core purpose of this 8-K filing is to disseminate these earnings results. The company reiterates its commitment to transparency by providing supplemental non-GAAP information, which has been a consistent reporting practice. Investors should note that these non-GAAP measures may differ from those reported by other companies and are not a substitute for GAAP-based reporting.
AGILENT TECHNOLOGIES, INC. 8-K Report, Bylaw Amendment (May 22, 2023)
Agilent Technologies, Inc. filed an 8-K on May 22, 2023, detailing an amendment to its bylaws approved by the Board of Directors on May 17, 2023. The most significant change grants stockholders holding at least 20% of the company's voting stock, continuously for at least one year, the right to call a special meeting. This new provision includes procedural safeguards to ensure meaningful disclosure from stockholders and to prevent redundant meetings close to annual shareholder gatherings. This amendment represents a shift towards greater stockholder empowerment, allowing a significant minority of shareholders to convene special meetings for specific purposes. Investors should note the threshold for calling such meetings (20% ownership for a minimum of one year) and the associated procedural requirements. While not a direct financial update, this corporate governance change can influence future shareholder activism and engagement.
AGILENT TECHNOLOGIES, INC. 8-K Report, Shareholder Vote Results (Mar 17, 2023)
Agilent Technologies, Inc. (A) filed an 8-K on March 17, 2023, reporting the outcomes of its Annual Meeting of Stockholders held on March 15, 2023. A significant majority of shares (approximately 90%) were represented, indicating strong shareholder engagement. All proposed items of business received overwhelming approval from shareholders. This includes the election of four directors, a non-binding advisory vote to approve executive compensation, and the ratification of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year 2023. Furthermore, shareholders approved amendments to the company's Certificate of Incorporation to allow stockholders holding at least 20% of voting stock to call a special meeting, a move that could enhance shareholder activism. The advisory vote on the frequency of executive compensation votes overwhelmingly favored a '1 Year' frequency, signaling a preference for annual say-on-pay votes. Overall, the results reflect broad shareholder confidence in the company's management, board, and governance practices.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Feb 28, 2023)
Agilent Technologies, Inc. (A) reported its financial results for the first fiscal quarter ended January 31, 2023, via a press release filed on February 28, 2023. The company emphasizes its use of non-GAAP financial information to provide supplemental insights into operational performance and management's view of core financial results. This non-GAAP data, which excludes items like restructuring and amortization to better reflect ongoing operating performance, is presented alongside GAAP results and is intended to enhance investor understanding by offering a view consistent with internal performance measurement and historical reporting.
AGILENT TECHNOLOGIES, INC. 8-K Report, Corporate Update (Jan 9, 2023)
Agilent Technologies, Inc. announced a significant $2 billion stock repurchase program authorized by its Board of Directors, effective March 1, 2023. This move signals management's confidence in the company's financial health and its commitment to returning value to shareholders. The substantial size of the program suggests a belief that the company's stock may be undervalued or that management sees strong future cash flow generation capabilities. Investors should note that this 8-K filing primarily serves to announce this new repurchase authorization, with the actual details and commencement date provided in an accompanying press release. While this news is positive for shareholders, it's important to monitor Agilent's future financial reports for how this program is executed and its impact on earnings per share and overall capital allocation strategy.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Nov 21, 2022)
Agilent Technologies, Inc. announced its financial results for the fourth fiscal quarter ended October 31, 2022, through a press release furnished via an 8-K filing. The company emphasized its use of non-GAAP financial measures to provide investors with supplemental insights into its core operational performance and future prospects, aligning with management's internal performance assessment and comparisons. These non-GAAP measures exclude certain items like restructuring and amortization that can impact GAAP earnings but are not used by management to evaluate ongoing operational performance. While the specific financial figures are detailed in the attached press release (Exhibit 99.1), the filing's primary purpose is to inform stakeholders about the company's performance using both GAAP and non-GAAP metrics. Investors should review the accompanying press release for detailed financial results and a comprehensive explanation of the non-GAAP adjustments made by Agilent.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (Aug 16, 2022)
Agilent Technologies, Inc. reported its financial results for the third fiscal quarter ended July 31, 2022, via a press release on August 16, 2022. The company emphasized its use of non-GAAP financial measures to provide a clearer view of its ongoing operational performance and prospects, aligning with how management assesses the business. These non-GAAP metrics, which exclude items like restructuring and amortization, are presented alongside GAAP results to offer supplemental insights and facilitate comparisons. Investors should note that while the press release offers valuable operational perspectives, the non-GAAP information may differ from measures used by other companies and is not a substitute for GAAP reporting. The filing primarily serves to furnish these financial results and related disclosures, with detailed explanations available in the attached Exhibit 99.1.
AGILENT TECHNOLOGIES, INC. 8-K Report, Financial Results (May 24, 2022)
Agilent Technologies, Inc. (A) announced its financial results for the second fiscal quarter ended April 30, 2022, via a press release filed on May 24, 2022. The company provided both GAAP and non-GAAP financial information, emphasizing that non-GAAP measures are intended to offer a clearer view of operational performance and enhance investor understanding of core financial performance and future prospects. These non-GAAP figures, which exclude items like restructuring and amortization, are used by management for internal and external comparisons and decision-making, providing a consistent view of ongoing operations. Investors should note that the non-GAAP financial information presented is not in accordance with U.S. Generally Accepted Accounting Principles (GAAP) and may differ from similar measures reported by other companies. The press release, attached as Exhibit 99.1, contains further details on these non-GAAP measures and the company's financial performance for the quarter. This filing primarily serves to furnish this earnings release and does not represent a change in the company's filed financial position or operations beyond the reported quarterly results.